J. Kolesar

hPG80 (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors

A. Prieur, B. Evers, L. Payen, 2022, Cancers.

Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations.

S. Edge, K. Nepple, J. Hopkins, 2023, JCO precision oncology.

A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas

M. Mahoney, H. Pitot, C. Erlichman, 2008, Investigational New Drugs.

Targetable IDH1 mutation identified in a rare case of pancreatic serous cystadenocarcinoma but not a series of serous cystadenomas

Chi Wang, Yuanyuan Wu, P. Pandalai, 2022, Journal of surgical case reports.

Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study.

P. Philip, M. Mahoney, H. Pitot, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action

M. Rech, J. Jacobi, Lamis R. Karaoui, 2021, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

A phase I does-escalation and expansion study of epidiolex (cannabidiol) in patients with biochemically recurrent prostate cancer.

Andrew C. James, R. DiPaola, S. Arnold, 2022, Journal of Clinical Oncology.

Osimertinib plus necitumumab in EGFR-mutant NSCLC: Final results from an ETCTN California Cancer Consortium phase I study.

S. Groshen, C. Paweletz, H. Wakelee, 2022, Journal of Clinical Oncology.

ASHP Foundation Pharmacy Forecast 2018: Strategic Planning Advice for Pharmacy Departments in Hospitals and Health Systems

Allen J. Flynn, W. A. Zellmer, J. Hoffman, 2018, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action executive summary

M. Rech, J. Jacobi, Lamis R. Karaoui, 2021, Journal of the American College of Clinical Pharmacy : JACCP.

Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810

R. DiPaola, L. Appleman, W. Harris, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.